Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peiwen Ma

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Journal of Cancer Research and Clinical Oncology|January 20, 2023
HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse eventsNing Jiang, Yue Yu, Dawei Wu, et al.
Journal of Hematology & Oncology|February 9, 2022
The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trialsDawei Wu, Huiyao Huang, Minghui Zhang, et al.
Cancer Letters|October 24, 2022
Drug conjugate-based anticancer therapy - Current status and perspectivesYuqi Yang, Shuhang Wang, Peiwen Ma, et al.
Drug Discovery Today|December 31, 2021
An overview of cancer drugs approved through expedited approval programs and orphan medicine designation globally between 2011 and 2020Shuhang Wang, Qiuyan Yang, Lan Deng, et al.
ACS Applied Materials & Interfaces|May 25, 2026
Temperature-Stable (1-<i>x</i>)Ba<sub>12</sub>Zn<sub>0.5</sub>Zr<sub>0.5</sub>Nb<sub>9</sub>O<sub>36</sub>-<i>x</i>BaWO<sub>4</sub> Composite Ceramics for Low-Temperature Co-Fired Ceramics and Dielectric Resonator Antenna ApplicationsZhen-Fa Yu, Zhi-Ji Wang, Chang-Hao Wang, et al.
Frontiers in Molecular Biosciences|April 1, 2022
KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese PatientsShuhang Wang, Qin Li, Peiwen Ma, et al.
Acta Pharmaceutica Sinica. B|June 3, 2024
Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood-brain barrierQiyu Tang, Guo Zhao, Hong Fang, et al.
Molecular Therapy Oncolytics|March 23, 2022
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trialsShuhang Wang, Yuqi Yang, Peiwen Ma, et al.
Frontiers in Immunology|September 30, 2022
Association between germ-line HLA and immune-related adverse eventsNing Jiang, Yue Yu, Min Zhang, et al.
Cancer Letters|June 2, 2024
Exosome-based anticancer vaccines: From Bench to bedsideGuo Zhao, Yuning Wang, Shujun Xing, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Cancer Research and Clinical Oncology|January 20, 2023
HLA and tumour immunology: immune escape, immunotherapy and immune-related adverse eventsNing Jiang, Yue Yu, Dawei Wu, et al.
Journal of Hematology & Oncology|February 9, 2022
The global landscape of neoadjuvant and adjuvant anti-PD-1/PD-L1 clinical trialsDawei Wu, Huiyao Huang, Minghui Zhang, et al.
Cancer Letters|October 24, 2022
Drug conjugate-based anticancer therapy - Current status and perspectivesYuqi Yang, Shuhang Wang, Peiwen Ma, et al.
Drug Discovery Today|December 31, 2021
An overview of cancer drugs approved through expedited approval programs and orphan medicine designation globally between 2011 and 2020Shuhang Wang, Qiuyan Yang, Lan Deng, et al.
ACS Applied Materials & Interfaces|May 25, 2026
Temperature-Stable (1-<i>x</i>)Ba<sub>12</sub>Zn<sub>0.5</sub>Zr<sub>0.5</sub>Nb<sub>9</sub>O<sub>36</sub>-<i>x</i>BaWO<sub>4</sub> Composite Ceramics for Low-Temperature Co-Fired Ceramics and Dielectric Resonator Antenna ApplicationsZhen-Fa Yu, Zhi-Ji Wang, Chang-Hao Wang, et al.
Frontiers in Molecular Biosciences|April 1, 2022
KRAS Mutation in Rare Tumors: A Landscape Analysis of 3453 Chinese PatientsShuhang Wang, Qin Li, Peiwen Ma, et al.
Acta Pharmaceutica Sinica. B|June 3, 2024
Nanoparticle drug delivery system for the treatment of brain tumors: Breaching the blood-brain barrierQiyu Tang, Guo Zhao, Hong Fang, et al.
Molecular Therapy Oncolytics|March 23, 2022
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trialsShuhang Wang, Yuqi Yang, Peiwen Ma, et al.
Frontiers in Immunology|September 30, 2022
Association between germ-line HLA and immune-related adverse eventsNing Jiang, Yue Yu, Min Zhang, et al.
Cancer Letters|June 2, 2024
Exosome-based anticancer vaccines: From Bench to bedsideGuo Zhao, Yuning Wang, Shujun Xing, et al.
Pageof 3